Physician profile
Wayne Karaki
NPI 1871582924
$2,916.75
in general payments reported to CMS, 2019-2025
31 companies · $759 in 2025
The $759 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $487 · 2023: $710 · 2024: $961 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,429.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $301.12 | 2022-2025 | Evenity, Prolia, Tepezza |
| Novo Nordisk INC | $279.87 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Medtronic, INC. | $250.44 | 2022-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Corcept Therapeutics | $239.22 | 2023-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $197.68 | 2022-2025 | |
| Dexcom, INC. | $165.27 | 2023-2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $160.68 | 2022-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $158.72 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $158.30 | 2023-2025 | |
| Lilly USA, LLC | $154.11 | 2022-2025 | Jardiance, Lyumjev, Baqsimi |
| Abbott Laboratories | $148.64 | 2022-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.26 | 2022-2024 | Jardiance |
| Nevro Corp. | $78.45 | 2022-2024 | Senza |
| Novartis Pharmaceuticals Corporation | $69.68 | 2022-2023 | |
| Radius Health, INC. | $51.25 | 2024-2025 | Tymlos |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $46.05 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Exact Sciences Corporation | $45.95 | 2023-2024 | Cologuard Collection Kit |
| Dynavax Technologies Corporation | $43.41 | 2022-2023 | Heplisav-B |
| Sequel Med Tech, LLC | $37.74 | 2025 | Twiist |
| Madrigal Pharmaceuticals | $36.48 | 2024 | Resmetirom |
| Neurocrine Biosciences, INC. | $23.07 | 2025 | |
| Kyowa Kirin, INC. | $20.30 | 2024 | Crysvita |
| Ascendis Pharma Endocrinology INC | $19.25 | 2023 | |
| Merck Sharp & Dohme LLC | $17.78 | 2022 | |
| Almatica Pharma LLC | $15.92 | 2024 | Teriparatide |
| Alexion Pharmaceuticals, INC. | $14.58 | 2024 | Strensiq |
| Xeris Pharmaceuticals, INC. | $13.99 | 2023 | Gvoke Hypopen |
| Cequr Corporation | $13.75 | 2022 | |
| Glaxosmithkline, LLC. | $13.70 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.61 | 2024 | Farxiga |
| Chiesi USA, INC. | $13.48 | 2025 | Mycapssa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Karaki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.